Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
Arcus Biosciences Inc (RCUS)
NYSE:RCUS
Arcus Biosciences (RCUS) Stock Price & Analysis
298 Followers
RCUS Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$15.70 - $39.75
Previous Close$17.62
Volume551.62K
Average Volume (3M)1.12M
Market Cap
$1.29B
Enterprise Value$279.65M
Total Cash (Recent Filing)$1.01B
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)-4.7
Beta1.27
Next Earnings
May 08, 2023EPS Estimate
-$1.16Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.71
Shares Outstanding73,011,325
10 Day Avg. Volume1,544,788
30 Day Avg. Volume1,115,265
Standard Deviation0.24
R-Squared0.04
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)1.96
Price to Sales (P/S)11.49
Price to Cash Flow (P/CF)2.90
P/FCF Ratio3.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.50
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-1.08
Forecast
1Y Price Target
$47.00Price Target Upside166.74% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering8
Arcus Biosciences News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
RCUS FAQ
What was Arcus Biosciences Inc’s price range in the past 12 months?
Arcus Biosciences Inc lowest stock price was $15.70 and its highest was $39.75 in the past 12 months.
What is Arcus Biosciences Inc’s market cap?
Currently, no data Available
When is Arcus Biosciences Inc’s upcoming earnings report date?
Arcus Biosciences Inc’s upcoming earnings report date is May 08, 2023 which is in 40 days.
How were Arcus Biosciences Inc’s earnings last quarter?
Arcus Biosciences Inc released its earnings results on Feb 28, 2023. The company reported -$0.93 earnings per share for the quarter, beating the consensus estimate of -$1.139 by $0.209.
Is Arcus Biosciences Inc overvalued?
According to Wall Street analysts Arcus Biosciences Inc’s price is currently Undervalued.
Does Arcus Biosciences Inc pay dividends?
Arcus Biosciences Inc does not currently pay dividends.
What is Arcus Biosciences Inc’s EPS estimate?
Arcus Biosciences Inc’s EPS estimate is -$1.16.
How many shares outstanding does Arcus Biosciences Inc have?
Arcus Biosciences Inc has 73,011,320 shares outstanding.
What happened to Arcus Biosciences Inc’s price movement after its last earnings report?
Arcus Biosciences Inc reported an EPS of -$0.93 in its last earnings report, beating expectations of -$1.139. Following the earnings report the stock price went down -4.338%.
Which hedge fund is a major shareholder of Arcus Biosciences Inc?
Among the largest hedge funds holding Arcus Biosciences Inc’s share is Invus Financial Advisors, LLC. It holds Arcus Biosciences Inc’s shares valued at 33M.
---
Arcus Biosciences Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$47.00 (166.74% Upside)
$47.00 (166.74% Upside)
Blogger Sentiment
Bullish
RCUS Sentiment 100%
Sector Average 68%
Sector Average 68%
Hedge Fund Trend
Increased
By 595.5K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $146.7K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.7%
Last 30 Days ▼ 5.7%
Last 30 Days ▼ 5.7%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-51.72%
12-Months-Change
Fundamentals
Return on Equity
-35.64%
Trailing 12-Months
Asset Growth
-15.51%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Arcus Biosciences Inc
Arcus Biosciences, Inc. engages in the development and commercialization of immunotherapies. The firm compete in the segments of the pharmaceutical, biotechnology and other related markets that develop immunotherapies for the treatment of cancer. The company was founded by Terry J. Rosen and Juan Carlos Jaen in 2015 and is headquartered in Hayward, CA.
---
Top 5 ETFs holding RCUS
iShares Biotechnology ETF
Invesco Dynamic Market ETF
iShares U.S. Tech Breakthrough Multisector ETF
Up to five ETFs with an Outperform Smart Score that hold RCUS. The ETFs are listed according to market value of RCUS within the ETF
---
Ultragenyx Pharmaceutical
―
Insmed
―
ACADIA Pharmaceuticals
―
BioCryst
―
SAGE Therapeutics
―
---